Vir Biotechnology Inc (MEX:VIR)
MXN 170 (0%) Market Cap: 27.36 Bil Enterprise Value: 19.87 Bil PE Ratio: 0 PB Ratio: 1.62 GF Score: 52/100

Vir Biotechnology Inc Annual Shareholders Meeting Transcript

May 26, 2026 / 04:00PM GMT
Release Date Price: MXN170
Operator

Good morning, and welcome to the Vir Biotechnology, Inc., Annual Meeting of Stockholders.

It is now my pleasure to turn over today's meeting to Dr. Marianne De Backer, President and CEO of Vir Biotechnology. Dr. De Backer, the floor is yours.

Marianne De Backer
Vir Biotechnology Inc - President, Chief Executive Officer, Director

Good morning. I'm Marianne De Backer, President and Chief Executive Officer of Vir Biotechnology. I would like to welcome all of you to Vir Biotechnology's 2026 Annual Meeting of Stockholders. As you know, we are hosting today's meeting through a virtual online platform. We have designed this meeting to provide stockholders with the same rights and opportunities to participate as they would at an in-person meeting.

Before I call the meeting to order, I'd like to take this opportunity to introduce you to the members of the Vir Biotechnology Board who are joining me today. They are Jeffrey Hatfield, Chair of our Nominating and Corporate Governance Committee and Member of our Audit Committee; Robert More, Chair of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot